# US 2019/0314052 A1 · Method for ablating body tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314052 A1
- Document ID: US20190314052A1
- Status: Published application
- Kind: A1
- Application number: 16/432,669
- Filed: 2019-06-05
- Published: 2019-10-17
- Earliest claimed: 2006-05-12
- Assignees: VrtronUS, Inc.
- Applicants: VrtronUS, Inc.
- Inventors: Hira V. Thapliyal; David A. Gallup; James W. Arenson
- Web page: https://patentgrep.com/patent/US20190314052A1

## CPC

- A61B 17/320068: {using mechanical vibrations, e.g. ultrasonic (A61B17/22012 takes precedence; dental tooth drilling devices operated by vibration A61C3/03; removing intra-ocular material using mechanical vibrations A61F9/00745)}
- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61N 7/02: Localised ultrasound hyperthermia
- A61N 7/022: {intracavitary}
- A61B 17/2202: {the ultrasound transducer being inside patient's body at the distal end of the catheter}
- A61B 18/24: with a catheter (A61B18/26, A61B18/28 take precedence)
- A61B 2017/00106: {ultrasonic}
- A61B 2017/00243: {cardiac}
- A61B 2017/003: {Steerable}
- A61B 2017/22024: {with a part reflecting mechanical vibrations, e.g. for focusing}
- A61B 2017/320069: {for ablating tissue}
- A61B 2018/00029: {open}
- A61N 2007/0078: {with multiple treatment transducers}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A cardiac ablation method including the following steps: inserting a treatment catheter into an atrium of a heart, the treatment catheter including an ultrasound emitter; positioning the ultrasound emitter to face heart tissue within the left atrium outside of a pulmonary vein; emitting ultrasound energy from the ultrasound emitter while rotating the ultrasound emitter about a rotation axis; and ablating heart tissue with the ultrasound energy to form a lesion outside of a pulmonary vein.

## Claims

### Claim 1

A tissue ablation system for creating a transmural lesion, the system comprising:
an ablation catheter comprising a proximal portion, a distal portion, and an ultrasound transducer disposed within the distal portion and is adapted to direct a collimated beam of ultrasound energy to a target tissue,
wherein the ultrasound transducer is adapted to operate in an ablation mode and a diagnostic mode,
wherein, in the ablation mode, the collimated beam of ultrasound energy is adapted to create a lesion in the target tissue to thereby ablate the target tissue. And
wherein, in the diagnostic mode, the ultrasound transducer is configured to act as a sensor to sense information about the target tissue based on a reflected ultrasound signal that is reflected back towards the ultrasound transducer by the target tissue;
a control mechanism operably coupled to the ablation catheter and adapted to rotate, translate, or bend the distal potion of the ablation catheters in order to sweep the collimated beam of ultrasound energy along an ablation path; and
a processor configured to adjust the sweep of the collimated beam of ultrasound energy based on the based on the sensed information to assure that the lesion is a transmural lesion.

### Claim 2 (depends on 1)

The system of claim 1, wherein the control mechanism is manually operated by a user.

### Claim 3 (depends on 1)

The system of claim 1, wherein the control mechanism is operated by a processor.

### Claim 4 (depends on 1)

The system of claim 1, wherein the ablation catheter is configured to regularly, on a time-shared basis, convert from the ablation mode briefly to the diagnostic mode to sense information about the target tissue.

### Claim 5 (depends on 1)

The system of claim 1, wherein a sweep rate of the collimated beam of ultrasound energy along the ablation path is configured to allow sufficient time for the lesion to develop.

### Claim 6 (depends on 1)

The system of claim 1, wherein the reflected ultrasound signal comprises an amplitude, wherein the amplitude depends on the type of target tissue sensed.

### Claim 7 (depends on 1)

The system of claim 1, wherein the sensed information comprises a residual tissue depth of the target tissue that has not been ablated.

### Claim 8 (depends on 1)

The system of claim 1, further comprising a generator operably coupled to the ultrasound transducer, wherein the generator is configured to automatically shut off if the sensed information indicates that the lesion is too deep into the target tissue.

### Claim 9 (depends on 1)

The system of claim 1, wherein the processor is configured to translate the distal portion of the ablation catheter to ensure that the ultrasound transducer is close enough to a surface of the target tissue for all movement throughout a cardiac cycle such that the entire movement is within a range for formation of the transmural lesion.

### Claim 10 (depends on 1)

The system of claim 1, further comprising a bending mechanism coupled to the ablation catheter and configured to bend the distal portion of the ablation catheter.

### Claim 11 (depends on 10)

The system of claim 10, wherein the bending mechanism comprises at least one pullwire, and wherein actuation of the at least one pullwire bends the distal portion of the ablation catheter.

### Claim 12 (depends on 10)

The system of claim 10, wherein the processor is connected to stepping motors operatively coupled to the control mechanism and the bending mechanism.

### Claim 13 (depends on 12)

The system of claim 12, wherein the processor is configured to control bending of the distal portion of the ablation catheter based on the sensed information.

### Claim 14 (depends on 1)

The system of claim 1, wherein the processor is configured to adjust a power delivered to the ultrasound transducer based on the sensed information.

### Claim 15 (depends on 1)

The system of claim 1, wherein the ablation catheter comprises a lumen through which a fluid is delivered to cool the ultrasound transducer.

### Claim 16 (depends on 1)

The system of claim 1, wherein the ultrasound transducer comprises a circular flat disc of less than 2.5 mm in diameter which is coated with a thin layer of metal and is adapted to produce more than 10 W of acoustic power output.

### Claim 17 (depends on 1)

The system of claim 1, further comprising a guide sheath through which the ablation catheter is delivered.

### Claim 18 (depends on 17)

The system of claim 17, wherein the ablation catheter is configured to translate and rotate relative to the guide sheath.

### Claim 19 (depends on 1)

The system of claim 1, wherein the ablation catheter comprises an inner catheter comprising, the ultrasound transducer and an outer catheter, and wherein the inner catheter is slidably disposed within the outer catheter.
